DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
SCD is a group of genetic disorders that cause red blood cells to become misshapen and break down. From an early age, patients with sickle cell disease have a high risk of vascular disease and even stroke. Current models to test drugs used to treat SCD are not reliable and cannot accurately predict how a person’s body will respond to the medication. It is also difficult to predict which patients with the disease have the highest risk of suffering a stroke versus those who have the lowest.
The team is designing an organ-on-a-chip, consisting of a device that will mimic an artery of a pediatric sickle cell disease patient, and the associated biological readouts will provide information on the progression of vaso-occlusion, including during drug treatment.
education & researchVaso-Occlusive Crises and Costs of Sickle Cell Disease in Patients With Commercial, Medicaid and Medicare Insurance ...Aim: To characterize vaso-occlusive cri...
education & researchPresence of pain on three or more days of the week is associated with worse patient reported outcomes in adults with...While acute episodic pain is the hallmar...
news & eventsStudy Confirms Safe Use of Opioids for Pain Control in Sickle Cell DiseaseThe most common cause of hospital admiss...
Community CenterToday’s Faces of Sickle Cell Disease: Jennelle StephensonJennelle Stephenson was diagnosed with S...
news & eventsCrizanlizumab designated FDA breakthrough therapy for potential in vaso-occlusive crisis preventionCrizanlizumab (SEG101), Novartis‘ inve...
news & eventsGut Microbiome Translates Stress Into Sickle Cell CrisesA new study shows how chronic psychologi...
news & eventsHow sickled red blood cells stick to blood vesselsOne of the most common complications o...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.